ALPHAMAB ONCOLO.DL-000002 Net Asset Quality Index
ALPHAMAB ONCOLO.DL-000002 net asset quality index. ALPHAMAB ONCOLO.DL-000002 (3NK) has a Net Asset Quality Index of 81.6% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.10 Billion minus total liabilities of €386.17 Million yields net assets of €1.71 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of ALPHAMAB ONCOLO.DL-000002 for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of ALPHAMAB ONCOLO.DL-000002 (2021–2025)
Net asset quality index of ALPHAMAB ONCOLO.DL-000002 from 2021 to 2025. This chart shows how ALPHAMAB ONCOLO.DL-000002's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 81.6%, representing net assets of €1.71 Billion against total assets of €2.10 Billion EUR. Check how tangible is ALPHAMAB ONCOLO.DL-000002's equity to evaluate the tangible quality of the company's equity base.
ALPHAMAB ONCOLO.DL-000002 Net Asset Quality Index by Year (2021–2025)
ALPHAMAB ONCOLO.DL-000002 net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for ALPHAMAB ONCOLO.DL-000002 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 3NK company net worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.6% | €1.71 Billion | €2.10 Billion | €386.17 Million | ▼ -0.1 pp |
| 2024 | 81.7% | €1.83 Billion | €2.24 Billion | €409.87 Million | ▲ +3.5 pp |
| 2023 | 78.2% | €1.67 Billion | €2.14 Billion | €465.00 Million | ▲ +4.7 pp |
| 2022 | 73.6% | €1.56 Billion | €2.12 Billion | €559.86 Million | ▲ +4.4 pp |
| 2021 | 69.1% | €1.87 Billion | €2.71 Billion | €834.80 Million | — |